About Qi decoction on platelet activation in patients with coronary heart disease rate of.docVIP

About Qi decoction on platelet activation in patients with coronary heart disease rate of.doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
 PAGE \* MERGEFORMAT 10 About Qi decoction on platelet activation in patients with coronary heart disease rate of [Abstract] Objective To observe Qi decoction on platelet activation in patients with coronary heart disease rates. Methods 75 patients with coronary heart disease were randomly divided into control group (35 cases) and treatment group (40 cases), conventional western medicine treatment for the control group the treatment group took Yiqihuoxue Chinese medicine, observed two groups before and after treatment of platelet membrane P selectin (CD62p) and platelet activating glycoprotein Gp Ⅱ b / Ⅲ a (PAC-1) expression. Results Yiqihuoxue Chinese medicine treatment for 2 months , platelet surface-active marker proteins CD62p, PAC-1 expression decreased, with its own control group before treatment and after treatment were significantly different (P lt;0.05). Conclusion Qi decoction on coronary heart disease patients have a good anti- platelet activation. [Keywords:] Yiqihuoxue Chinese medicine, coronary heart disease, platelet activation Common for the elderly with coronary heart disease, atherosclerosis and thrombosis is based on the pathological, and platelet activation and blood coagulation system is the combined effect of thrombus formation. Research shows that patients with coronary heart disease in a high activation state of platelets in general, is thrombosis high-risk patients [1], and P selectin (CD62p) is a platelet activation mark. With coronary disease increased, CD62p activity was significantly increased [2], and platelet-activating glycoprotein Gp Ⅱ b / Ⅲ a (PAC-1) is Early detection of platelet activation and effective means. Yiqihuoxue my experience in the prescription for the party, and coronary heart disease have better clinical efficacy. To investigate the mechanism of its efficacy, this study CD62p, PAC-1 for the detection index, to observe its platelet activation in patients with coronary heart disease-positive rate. 1 Mate

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档